SC
AKCA

Sculptor Capital’s Akcea Therapeutics Inc AKCA Stock Holding History

Sculptor Capital’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,000
Closed -$102K – 333
2019
Q4 		$102K Sell
6,000
-181,500
-97% -$3.38M ﹤0.01% 265
2019
Q3 		$2.89M Sell
187,500
-14,100
-7% -$300K 0.03% 158
2019
Q2 		$4.73M Hold
201,600
– – 0.02% 129
2019
Q1 		$5.71M Buy
201,600
+94,400
+88% +$2.75M 0.03% 93
2018
Q4 		$3.23M Hold
107,200
– – 0.02% 104
2018
Q3 		$3.75M Buy
+107,200
New +$3.24M 0.02% 116

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sculptor Capital's AKCA Position: Q1 2020 in Review

Sculptor Capital sold out of Akcea Therapeutics Inc (AKCA) in Q1 2020, closing a stake of 4,600 shares — an estimated $78K sold.

Sculptor Capital first reported a position in AKCA in Q3 2018 and held it in 6 quarters. The position peaked at $5.67M in Q1 2019. 77 funds tracked by Wall St. Rank hold AKCA as of Q1 2020.

  • Sculptor Capital reported no remaining Akcea Therapeutics Inc position as of Q1 2020 after selling out during the quarter.
  • Sculptor Capital sold 4,600 Akcea Therapeutics Inc shares in Q1 2020, an estimated $78K.
  • Sculptor Capital first reported a position in Akcea Therapeutics Inc in Q3 2018 and held it in 6 quarters.
  • Sculptor Capital's Akcea Therapeutics Inc position peaked at $5.67M in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2020.

Based on Sculptor Capital's 13F filing for Q1 2020, filed 14 May 2020.